Free Trial

BeyondSpring (NASDAQ:BYSI) Releases Quarterly Earnings Results

BeyondSpring logo with Medical background

Key Points

  • BeyondSpring reported a quarterly earnings loss of ($0.04) earnings per share (EPS), reflecting its ongoing challenges in the biopharmaceutical sector.
  • The company's stock recently traded at $2.01, with a significant 12-month trading range between $0.98 and $3.44.
  • Institutional investor Geode Capital Management LLC increased its stake in BeyondSpring by 951.4%, now owning 40.29% of the company's stock.
  • Looking to export and analyze BeyondSpring data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

BeyondSpring (NASDAQ:BYSI - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.04) earnings per share for the quarter, Zacks reports.

BeyondSpring Trading Down 5.4%

BYSI stock traded down $0.10 during midday trading on Tuesday, reaching $1.75. 51,279 shares of the company's stock traded hands, compared to its average volume of 29,263. BeyondSpring has a fifty-two week low of $0.98 and a fifty-two week high of $3.44. The business has a 50-day moving average price of $2.29 and a two-hundred day moving average price of $1.86.

Hedge Funds Weigh In On BeyondSpring

An institutional investor recently raised its position in BeyondSpring stock. Geode Capital Management LLC boosted its stake in BeyondSpring Inc. (NASDAQ:BYSI - Free Report) by 951.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 256,212 shares of the company's stock after purchasing an additional 231,844 shares during the period. Geode Capital Management LLC owned approximately 0.64% of BeyondSpring worth $603,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 40.29% of the company's stock.

BeyondSpring Company Profile

(Get Free Report)

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.

Further Reading

Earnings History for BeyondSpring (NASDAQ:BYSI)

Should You Invest $1,000 in BeyondSpring Right Now?

Before you consider BeyondSpring, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.

While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines